Cite
MLA Citation
T.C. Lam et al.. “Combination atezolizumab, bevacizumab, pemetrexed and carboplatin for metastatic EGFR mutated NSCLC after TKI failure.” Lung cancer, vol. 159, 2021, pp. 18–26. http://access.bl.uk/ark:/81055/vdc_100139616026.0x000054